BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS AND Treatment
14 results:

  • 1. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
    Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
    Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
    Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
    Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
    Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
    Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Efficacy and Safety of Sintilimab Plus Anlotinib for PD-L1-Positive Recurrent or Metastatic cervical cancer: A Multicenter, Single-Arm, Prospective Phase II Trial.
    Xu Q; Wang J; Sun Y; Lin Y; Liu J; Zhuo Y; Huang Z; Huang S; Chen Y; Chen L; Ke M; Li L; Li Z; Pan J; Song Y; Liu R; Chen C
    J Clin Oncol; 2022 Jun; 40(16):1795-1805. PubMed ID: 35192397
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial.
    Huang X; He M; Peng H; Tong C; Liu Z; Zhang X; Shao Y; Zhu D; Zhang J; Yin JC; Yang F; Lan C
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011535
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with
    Jhaveri K; Chang MT; Juric D; Saura C; Gambardella V; Melnyk A; Patel MR; Ribrag V; Ma CX; Aljumaily R; Bedard PL; Sachdev JC; Dunn L; Won H; Bond J; Jones S; Savage HM; Scaltriti M; Wilson TR; Wei MC; Hyman DM
    Clin Cancer Res; 2021 Jan; 27(2):447-459. PubMed ID: 33148674
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. lkb1 loss is associated with glutathione deficiency under oxidative stress and sensitivity of cancer cells to cytotoxic drugs and γ-irradiation.
    Zulato E; Ciccarese F; Agnusdei V; Pinazza M; Nardo G; Iorio E; Curtarello M; Silic-Benussi M; Rossi E; Venturoli C; Panieri E; Santoro MM; Di Paolo V; Quintieri L; Ciminale V; Indraccolo S
    Biochem Pharmacol; 2018 Oct; 156():479-490. PubMed ID: 30222967
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in cervical cancer Patients.
    de la Rochefordiere A; Kamal M; Floquet A; Thomas L; Petrow P; Petit T; Pop M; Fabbro M; Kerr C; Joly F; Sevin E; Maillard S; Curé H; Weber B; Brunaud C; Minsat M; Gonzague L; Berton-Rigaud D; Aumont M; Gladieff L; Peignaux K; Bernard V; Leroy Q; Bieche I; Margogne A; Nadan A; Fourchotte V; Diallo A; Asselain B; Plancher C; Armanet S; Beuzeboc P; Scholl SM
    Clin Cancer Res; 2015 Jun; 21(11):2530-7. PubMed ID: 25724520
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Successful pregnancy in a Peutz-Jeghers syndrome patient with lobular endocervical glandular hyperplasia.
    Takei Y; Fujiwara H; Nagashima T; Takahashi Y; Takahashi S; Suzuki M
    J Obstet Gynaecol Res; 2015 Mar; 41(3):468-73. PubMed ID: 25257303
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Metformin impairs the growth of liver kinase B1-intact cervical cancer cells.
    Xiao X; He Q; Lu C; Werle KD; Zhao RX; Chen J; Davis BC; Cui R; Liang J; Xu ZX
    Gynecol Oncol; 2012 Oct; 127(1):249-55. PubMed ID: 22735790
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Inhibition of cervical cancer cell growth through activation of upstream kinases of AMP-activated protein kinase.
    Yu SY; Chan DW; Liu VW; Ngan HY
    Tumour Biol; 2009; 30(2):80-5. PubMed ID: 19407487
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of lkb1.
    Nafz J; De-Castro Arce J; Fleig V; Patzelt A; Mazurek S; Rösl F
    Biochem J; 2007 May; 403(3):501-10. PubMed ID: 17212587
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Epigenetic inactivation of lkb1 in primary tumors associated with the Peutz-Jeghers syndrome.
    Esteller M; Avizienyte E; Corn PG; Lothe RA; Baylin SB; Aaltonen LA; Herman JG
    Oncogene; 2000 Jan; 19(1):164-8. PubMed ID: 10644993
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome.
    Srivatsa PJ; Keeney GL; Podratz KC
    Gynecol Oncol; 1994 May; 53(2):256-64. PubMed ID: 8188091
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.